AXTA insider sale: SVP & CHRO sold 3,194 shares at $31.06
A company officer, Amy Tufano (SVP & CHRO) reported an open-market sale of 3,194 Axalta Coating Systems Ltd. (AXTA) common shares on 08/19/2025 at an average price of $31.06 per share.
Rhea-AI Filing Summary
A company officer, Amy Tufano (SVP & CHRO) reported an open-market sale of 3,194 Axalta Coating Systems Ltd. (AXTA) common shares on 08/19/2025 at an average price of $31.06 per share. After the sale she beneficially owned 12,087 shares. The Form 4 was signed by an attorney-in-fact on 08/21/2025. The filing indicates this was a direct disposition of shares and does not list any derivative transactions or additional remarks.
Positive
- None.
Negative
- Officer disposed of 3,194 AXTA shares, which reduced direct beneficial ownership to 12,087 shares
Insights
TL;DR: Insider sale of 3,194 AXTA shares by an officer, reducing holdings to 12,087—routine disclosure, not necessarily material.
The filing shows a direct open-market sale reported under Section 16. The transaction size and resulting holding are explicitly stated: sale of 3,194 shares at $31.06 and remaining beneficial ownership of 12,087 shares. There are no derivative transactions, no plan designation noted, and no additional explanatory remarks. From an investor-disclosure perspective this is a standard Form 4 reporting an officer disposition and contains no signals of company-level events or changes in control.
TL;DR: Routine officer share sale disclosed correctly; documentation appears complete for a single non-derivative transaction.
The report identifies the reporting persons role (SVP & CHRO), the transaction date (08/19/2025), transaction code (S for sale), quantity sold (3,194), price ($31.06), and post-transaction ownership (12,087). The form indicates individual filing and includes an attorney-in-fact signature. There are no amendments or explanatory notes attached. This meets basic Section 16 reporting requirements for a direct disposition.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Shares | 3,194 | $31.06 | $99K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Amy Tufano report on Form 4 for AXTA?
Was the Form 4 filing for AXTA an individual or joint filing?
Did the Form 4 for AXTA disclose any derivative transactions or option exercises?
When was the Form 4 for AXTA signed and who signed it?
What transaction code is used for the sale reported on the AXTA Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.